HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 494 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $606,326 | +79.4% | 5,328 | -2.3% | 0.08% | +80.0% |
| Q3 2022 | $338,000 | -23.7% | 5,455 | -1.8% | 0.04% | -8.2% |
| Q2 2022 | $443,000 | -25.2% | 5,557 | -1.2% | 0.05% | -12.5% |
| Q1 2022 | $592,000 | -2.3% | 5,627 | +0.1% | 0.06% | +16.7% |
| Q4 2021 | $606,000 | -3.2% | 5,624 | -1.6% | 0.05% | -7.7% |
| Q3 2021 | $626,000 | +17.0% | 5,718 | 0.0% | 0.05% | +20.9% |
| Q2 2021 | $535,000 | -83.3% | 5,718 | -83.6% | 0.04% | -84.8% |
| Q1 2021 | $3,211,000 | +152.0% | 34,889 | +100.3% | 0.28% | +161.1% |
| Q4 2020 | $1,274,000 | -48.9% | 17,420 | -45.7% | 0.11% | -48.6% |
| Q3 2020 | $2,493,000 | -83.6% | 32,095 | -88.3% | 0.21% | -84.4% |
| Q2 2020 | $15,216,000 | -18.5% | 273,762 | -56.6% | 1.34% | -39.0% |
| Q1 2020 | $18,673,000 | -50.2% | 630,429 | -54.2% | 2.20% | -23.6% |
| Q3 2019 | $37,470,000 | +19.9% | 1,376,066 | +5.9% | 2.88% | +25.3% |
| Q2 2019 | $31,249,000 | – | 1,298,796 | – | 2.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |